Page 13 - Peter Greenleaf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Aurinia to receive $50 million U.S. upfront payment in addition to up to $50 million U.S. in regulatory and reimbursement milestone payments – – Agreement includes royalties of up to 20 percent on net sales payable to Aurinia – Aurinia Pharmaceuticals Inc. today announced it has entered into a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of oral … ...

DGAP-News: Immun ... DGAP-News: Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US vom 17.12.2020, 09:00 Uhr Bild: pixabay.com DGAP-News: Immune Regulation Limited / Key word(s): Personnel Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US 17.12.2020 / 09:00 The issuer is solely responsible for the content of this announcement. Immune Regulation appoints New Chairman and builds out S...

Immune Regulation Limited Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US DGAP-News: Immune Regulation Limited / Key word(s): Personnel Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US 17.12.2020 / 09:00 The issuer is solely responsible for the content of this announcement. Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US (London UK, New Or...

Search jobs 17-Dec-2020 Immune Regulation Appoints New Chairman and Builds Out Senior Management Team with Standout Industry Professionals in the US LONDON, UK and NEW ORLEANS, US, December 17, 2020 / B3C newswire / --Immune Regulation Ltd, a US and UK based clinical stage biotechnology company announced today a series of appointments to build out the Board and leadership team that will work alongside Jonathan Rigby, Group CEO of Immune Regulation, in advancing the development of its first-in-class immune resetting therapies for autoimmune and alle...